0001209191-18-056114.txt : 20181024
0001209191-18-056114.hdr.sgml : 20181024
20181024205522
ACCESSION NUMBER: 0001209191-18-056114
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181015
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arenberg Michael
CENTRAL INDEX KEY: 0001755509
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31615
FILM NUMBER: 181137421
MAIL ADDRESS:
STREET 1: 10260 BUBB ROAD
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DURECT CORP
CENTRAL INDEX KEY: 0001082038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943297098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10260 BUBB RD
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 4087771417
MAIL ADDRESS:
STREET 1: 10260 BUBB ROAD
CITY: CUPERTINO
STATE: CA
ZIP: 95014
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-10-15
0
0001082038
DURECT CORP
DRRX
0001755509
Arenberg Michael
10260 BUBB ROAD
CUPERTINO
CA
95014
0
1
0
0
Chief Financial Officer
Common Stock
14426
D
Incentive Stock Option (right to buy)
3.11
2019-01-27
Common Stock
10938
D
Incentive Stock Option (right to buy)
2.80
2019-02-13
Common Stock
7813
D
Incentive Stock Option (right to buy)
2.09
2019-05-21
Common Stock
7169
D
Incentive Stock Option (right to buy)
2.18
2020-01-22
Common Stock
25000
D
Incentive Stock Option (right to buy)
3.26
2021-01-20
Common Stock
45255
D
Incentive Stock Option (right to buy)
1.21
2023-02-05
Common Stock
50625
D
Incentive Stock Option (right to buy)
2.09
2024-01-31
Common Stock
63017
D
Incentive Stock Option (right to buy)
0.88
2025-01-09
Common Stock
76328
D
Incentive Stock Option (right to buy)
1.16
2026-01-28
Common Stock
61750
D
Incentive Stock Option (right to buy)
1.31
2027-01-09
Common Stock
2464
D
Incentive Stock Option (right to buy)
1.31
2027-01-09
Common Stock
69469
D
Non-Qualified Stock Option (right to buy)
3.11
2019-01-27
Common Stock
24062
D
Non-Qualified Stock Option (right to buy)
2.80
2019-02-13
Common Stock
17187
D
Non-Qualified Stock Option (right to buy)
2.09
2019-05-21
Common Stock
35831
D
Non-Qualified Stock Option (right to buy)
2.18
2020-01-22
Common Stock
18791
D
Non-Qualified Stock Option (right to buy)
2.18
2020-01-22
Common Stock
55000
D
Non-Qualified Stock Option (right to buy)
3.26
2021-01-20
Common Stock
74745
D
Non-Qualified Stock Option (right to buy)
1.21
2023-02-05
Common Stock
39375
D
Non-Qualified Stock Option (right to buy)
1.21
2023-02-05
Common Stock
51260
D
Non-Qualified Stock Option (right to buy)
2.09
2024-01-31
Common Stock
26983
D
Non-Qualified Stock Option (right to buy)
2.09
2024-01-31
Common Stock
39167
D
Non-Qualified Stock Option (right to buy)
0.88
2025-01-09
Common Stock
57808
D
Non-Qualified Stock Option (right to buy)
0.88
2025-01-09
Common Stock
18672
D
Non-Qualified Stock Option (right to buy)
1.16
2026-01-28
Common Stock
43983
D
Non-Qualified Stock Option (right to buy)
1.16
2026-01-28
Common Stock
14250
D
Non-Qualified Stock Option (right to buy)
1.31
2027-01-09
Common Stock
52306
D
Non-Qualified Stock Option (right to buy)
1.31
2027-01-09
Common Stock
16031
D
Non-Qualified Stock Option (right to buy)
1.40
2027-06-19
Common Stock
10000
D
Fully vested as of the date of this filing.
This ISO option Grant Dated January 9, 2015 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date.
This ISO option Grant Dated January 28, 2016 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date.
This ISO option Grant Dated January 9, 2017 will vest as follows: 1/16 of the total shares subject to the option shall vest quarterly over 4 years following the Grant Date.
Following the time the reporting person became an executive officer, but prior to the filing of this Form 3, the reporting person was granted certain stock options that were reported on Form 4 and filed on October 17, 2018.
/s/ Michael Arenberg
2018-10-24